跳至主要内容
临床试验/JPRN-UMIN000015101
JPRN-UMIN000015101已完成1 期

A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinoma - A phase 1 trial of HAIC with high dose CDDP + 5-FU for advanced HCC

Keio University, School of medicine, Department of Surgery0 个研究点目标入组 18 人开始时间: 2014年9月10日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Active second primary malignancies. (2) Within 3 years after radical treatment of another cancer (3) With extrahepatic metastasis. (4) Patients with ascites possessed clinical meaning. (5) Hepatic Encephalopathy (6) Critical renal failure or hemodialysis (7) Contraindication of CDDP and 5-FU (8) Any patients are pregnant/ nursing (9) After administration of TS-1 (10) Auditory disorder (11) Patients with serious infection (12) Gastrointestinal ulcer or bleeding (13) Uncontrolled DM (14) Those judged to be not suitable by the attending physician

研究者

发起方
Keio University, School of medicine, Department of Surgery

相似试验